External broker reports(aggregated public sources), Taylor Collison

Taylor Collison

Taylor Collison is a leading financial services firm, providing advice & wealth creation strategies to private & institutional investors and corporate clients throughout Australia. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<ul><li>GSS expects to submit responses by the end of April to FDA questions regarding its 510(k) application to market the GIP kit in the US.</li><li>We continue to anticipate an FDA decision by early June at the latest.</li><li>GSS has installed instruments at 6 US labs as customer experience sites, with a further 3 to be installed this qtr. This should allow a rapid start to commercial sales if the GIP kit wins FDA clearance.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

GSS expects to submit responses by the end of April to FDA questions regarding its 510(k) application to market the GIP kit in the US.We continue to anticipate an FDA decision by early June at the latest.GSS has installed instruments at 6 US labs as customer experience sites, with a further 3 to be installed this qtr. This should allow a rapid start to commercial sales if the GIP kit wins FDA clearance.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Genetic Signatures (GSS) - On Track for Potential US Launch Mid-Year